Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions.
D000937:Antigen-Antibody Reactions; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003872:Dermatitis / Q000188:drug therapy; D003877:Dermatitis, Contact; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006097:Granulation Tissue / Q000503:physiopathology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007642:Keratosis / Q000188:drug therapy; D007971:Leukoplakia / Q000188:drug therapy; D008297:Male; D009364:Neoplasm Recurrence, Local; D009578:Nitrobenzenes / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000276:immunology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D014228:Triaziquone / Q000627:therapeutic use*; D014945:Wound Healing
D009578:Nitrobenzenes; D014228:Triaziquone; D005472:Fluorouracil